nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydromorphone—UGT1A9—Irinotecan—colon cancer	0.392	0.62	CbGbCtD
Hydromorphone—CYP2C9—Capecitabine—colon cancer	0.106	0.168	CbGbCtD
Hydromorphone—CYP2C9—Fluorouracil—colon cancer	0.0628	0.0994	CbGbCtD
Hydromorphone—CYP3A4—Irinotecan—colon cancer	0.038	0.0602	CbGbCtD
Hydromorphone—CYP3A4—Vincristine—colon cancer	0.0333	0.0527	CbGbCtD
Hydromorphone—Naltrexone—ABCB1—colon cancer	0.00083	0.349	CrCbGaD
Hydromorphone—Naloxone—ABCB1—colon cancer	0.000606	0.255	CrCbGaD
Hydromorphone—Cough—Irinotecan—colon cancer	0.000548	0.0015	CcSEcCtD
Hydromorphone—Weight decreased—Capecitabine—colon cancer	0.000546	0.00149	CcSEcCtD
Hydromorphone—Hypertension—Irinotecan—colon cancer	0.000543	0.00148	CcSEcCtD
Hydromorphone—Leukopenia—Fluorouracil—colon cancer	0.000539	0.00147	CcSEcCtD
Hydromorphone—Infestation NOS—Capecitabine—colon cancer	0.000538	0.00147	CcSEcCtD
Hydromorphone—Infestation—Capecitabine—colon cancer	0.000538	0.00147	CcSEcCtD
Hydromorphone—Anaphylactoid reaction—Methotrexate—colon cancer	0.000537	0.00147	CcSEcCtD
Hydromorphone—Depression—Capecitabine—colon cancer	0.000537	0.00147	CcSEcCtD
Hydromorphone—Lethargy—Methotrexate—colon cancer	0.000531	0.00145	CcSEcCtD
Hydromorphone—Discomfort—Irinotecan—colon cancer	0.000529	0.00144	CcSEcCtD
Hydromorphone—Anaphylactic shock—Vincristine—colon cancer	0.000527	0.00144	CcSEcCtD
Hydromorphone—Stomatitis—Capecitabine—colon cancer	0.000525	0.00143	CcSEcCtD
Hydromorphone—Infection—Vincristine—colon cancer	0.000523	0.00143	CcSEcCtD
Hydromorphone—Convulsion—Fluorouracil—colon cancer	0.000522	0.00143	CcSEcCtD
Hydromorphone—Osteoarthritis—Methotrexate—colon cancer	0.00052	0.00142	CcSEcCtD
Hydromorphone—Confusional state—Irinotecan—colon cancer	0.000517	0.00141	CcSEcCtD
Hydromorphone—Nervous system disorder—Vincristine—colon cancer	0.000517	0.00141	CcSEcCtD
Hydromorphone—Anaphylactic shock—Irinotecan—colon cancer	0.000513	0.0014	CcSEcCtD
Hydromorphone—Chest pain—Fluorouracil—colon cancer	0.000512	0.0014	CcSEcCtD
Hydromorphone—Myalgia—Fluorouracil—colon cancer	0.000512	0.0014	CcSEcCtD
Hydromorphone—Morphine—ABCB1—colon cancer	0.000511	0.215	CrCbGaD
Hydromorphone—Infection—Irinotecan—colon cancer	0.00051	0.00139	CcSEcCtD
Hydromorphone—Hyperhidrosis—Vincristine—colon cancer	0.000509	0.00139	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Capecitabine—colon cancer	0.000509	0.00139	CcSEcCtD
Hydromorphone—Discomfort—Fluorouracil—colon cancer	0.000506	0.00138	CcSEcCtD
Hydromorphone—Shock—Irinotecan—colon cancer	0.000505	0.00138	CcSEcCtD
Hydromorphone—Nervous system disorder—Irinotecan—colon cancer	0.000503	0.00137	CcSEcCtD
Hydromorphone—Anorexia—Vincristine—colon cancer	0.000502	0.00137	CcSEcCtD
Hydromorphone—Hyperhidrosis—Irinotecan—colon cancer	0.000496	0.00135	CcSEcCtD
Hydromorphone—Confusional state—Fluorouracil—colon cancer	0.000495	0.00135	CcSEcCtD
Hydromorphone—Mood swings—Methotrexate—colon cancer	0.000493	0.00135	CcSEcCtD
Hydromorphone—Hypotension—Vincristine—colon cancer	0.000492	0.00134	CcSEcCtD
Hydromorphone—Bradycardia—Capecitabine—colon cancer	0.000492	0.00134	CcSEcCtD
Hydromorphone—Anaphylactic shock—Fluorouracil—colon cancer	0.000491	0.00134	CcSEcCtD
Hydromorphone—Anorexia—Irinotecan—colon cancer	0.000489	0.00134	CcSEcCtD
Hydromorphone—Infection—Fluorouracil—colon cancer	0.000488	0.00133	CcSEcCtD
Hydromorphone—Rhinitis—Capecitabine—colon cancer	0.000484	0.00132	CcSEcCtD
Hydromorphone—Nervous system disorder—Fluorouracil—colon cancer	0.000482	0.00132	CcSEcCtD
Hydromorphone—Hypoaesthesia—Capecitabine—colon cancer	0.000481	0.00131	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Vincristine—colon cancer	0.00048	0.00131	CcSEcCtD
Hydromorphone—Tachycardia—Fluorouracil—colon cancer	0.000479	0.00131	CcSEcCtD
Hydromorphone—Hypotension—Irinotecan—colon cancer	0.000479	0.00131	CcSEcCtD
Hydromorphone—Urinary tract disorder—Capecitabine—colon cancer	0.000477	0.0013	CcSEcCtD
Hydromorphone—Insomnia—Vincristine—colon cancer	0.000476	0.0013	CcSEcCtD
Hydromorphone—Oedema peripheral—Capecitabine—colon cancer	0.000476	0.0013	CcSEcCtD
Hydromorphone—Connective tissue disorder—Capecitabine—colon cancer	0.000475	0.0013	CcSEcCtD
Hydromorphone—Urethral disorder—Capecitabine—colon cancer	0.000474	0.00129	CcSEcCtD
Hydromorphone—Paraesthesia—Vincristine—colon cancer	0.000473	0.00129	CcSEcCtD
Hydromorphone—Breast disorder—Methotrexate—colon cancer	0.00047	0.00128	CcSEcCtD
Hydromorphone—Anorexia—Fluorouracil—colon cancer	0.000468	0.00128	CcSEcCtD
Hydromorphone—Visual impairment—Capecitabine—colon cancer	0.000466	0.00127	CcSEcCtD
Hydromorphone—Insomnia—Irinotecan—colon cancer	0.000464	0.00127	CcSEcCtD
Hydromorphone—Paraesthesia—Irinotecan—colon cancer	0.000461	0.00126	CcSEcCtD
Hydromorphone—Hypotension—Fluorouracil—colon cancer	0.000459	0.00125	CcSEcCtD
Hydromorphone—Decreased appetite—Vincristine—colon cancer	0.000458	0.00125	CcSEcCtD
Hydromorphone—Dyspnoea—Irinotecan—colon cancer	0.000457	0.00125	CcSEcCtD
Hydromorphone—Somnolence—Irinotecan—colon cancer	0.000456	0.00125	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Vincristine—colon cancer	0.000455	0.00124	CcSEcCtD
Hydromorphone—Fatigue—Vincristine—colon cancer	0.000454	0.00124	CcSEcCtD
Hydromorphone—Eye disorder—Capecitabine—colon cancer	0.000452	0.00123	CcSEcCtD
Hydromorphone—Dyspepsia—Irinotecan—colon cancer	0.000452	0.00123	CcSEcCtD
Hydromorphone—Tinnitus—Capecitabine—colon cancer	0.000451	0.00123	CcSEcCtD
Hydromorphone—Pain—Vincristine—colon cancer	0.00045	0.00123	CcSEcCtD
Hydromorphone—Constipation—Vincristine—colon cancer	0.00045	0.00123	CcSEcCtD
Hydromorphone—Asthma—Methotrexate—colon cancer	0.000449	0.00123	CcSEcCtD
Hydromorphone—Flushing—Capecitabine—colon cancer	0.000448	0.00123	CcSEcCtD
Hydromorphone—Cardiac disorder—Capecitabine—colon cancer	0.000448	0.00123	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000448	0.00122	CcSEcCtD
Hydromorphone—Decreased appetite—Irinotecan—colon cancer	0.000446	0.00122	CcSEcCtD
Hydromorphone—Insomnia—Fluorouracil—colon cancer	0.000444	0.00121	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Irinotecan—colon cancer	0.000443	0.00121	CcSEcCtD
Hydromorphone—Fatigue—Irinotecan—colon cancer	0.000442	0.00121	CcSEcCtD
Hydromorphone—Paraesthesia—Fluorouracil—colon cancer	0.000441	0.00121	CcSEcCtD
Hydromorphone—Constipation—Irinotecan—colon cancer	0.000439	0.0012	CcSEcCtD
Hydromorphone—Pain—Irinotecan—colon cancer	0.000439	0.0012	CcSEcCtD
Hydromorphone—Angiopathy—Capecitabine—colon cancer	0.000438	0.0012	CcSEcCtD
Hydromorphone—Dyspnoea—Fluorouracil—colon cancer	0.000438	0.0012	CcSEcCtD
Hydromorphone—Somnolence—Fluorouracil—colon cancer	0.000437	0.00119	CcSEcCtD
Hydromorphone—Immune system disorder—Capecitabine—colon cancer	0.000436	0.00119	CcSEcCtD
Hydromorphone—Mediastinal disorder—Capecitabine—colon cancer	0.000436	0.00119	CcSEcCtD
Hydromorphone—Chills—Capecitabine—colon cancer	0.000434	0.00118	CcSEcCtD
Hydromorphone—Dyspepsia—Fluorouracil—colon cancer	0.000432	0.00118	CcSEcCtD
Hydromorphone—Arrhythmia—Capecitabine—colon cancer	0.000432	0.00118	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Vincristine—colon cancer	0.000431	0.00118	CcSEcCtD
Hydromorphone—Dextromethorphan—ABCB1—colon cancer	0.000429	0.181	CrCbGaD
Hydromorphone—Decreased appetite—Fluorouracil—colon cancer	0.000427	0.00117	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000424	0.00116	CcSEcCtD
Hydromorphone—Mental disorder—Capecitabine—colon cancer	0.000423	0.00116	CcSEcCtD
Hydromorphone—Feeling abnormal—Irinotecan—colon cancer	0.000423	0.00115	CcSEcCtD
Hydromorphone—Erythema—Capecitabine—colon cancer	0.000421	0.00115	CcSEcCtD
Hydromorphone—Malnutrition—Capecitabine—colon cancer	0.000421	0.00115	CcSEcCtD
Hydromorphone—Dysuria—Methotrexate—colon cancer	0.00042	0.00115	CcSEcCtD
Hydromorphone—Pain—Fluorouracil—colon cancer	0.00042	0.00115	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Irinotecan—colon cancer	0.000419	0.00115	CcSEcCtD
Hydromorphone—Body temperature increased—Vincristine—colon cancer	0.000416	0.00114	CcSEcCtD
Hydromorphone—Abdominal pain—Vincristine—colon cancer	0.000416	0.00114	CcSEcCtD
Hydromorphone—Flatulence—Capecitabine—colon cancer	0.000415	0.00113	CcSEcCtD
Hydromorphone—Erectile dysfunction—Methotrexate—colon cancer	0.000414	0.00113	CcSEcCtD
Hydromorphone—Dysgeusia—Capecitabine—colon cancer	0.000412	0.00113	CcSEcCtD
Hydromorphone—Back pain—Capecitabine—colon cancer	0.000407	0.00111	CcSEcCtD
Hydromorphone—Abdominal pain—Irinotecan—colon cancer	0.000406	0.00111	CcSEcCtD
Hydromorphone—Body temperature increased—Irinotecan—colon cancer	0.000406	0.00111	CcSEcCtD
Hydromorphone—Feeling abnormal—Fluorouracil—colon cancer	0.000405	0.00111	CcSEcCtD
Hydromorphone—Muscle spasms—Capecitabine—colon cancer	0.000404	0.0011	CcSEcCtD
Hydromorphone—Drowsiness—Methotrexate—colon cancer	0.000401	0.00109	CcSEcCtD
Hydromorphone—Infestation NOS—Methotrexate—colon cancer	0.000401	0.00109	CcSEcCtD
Hydromorphone—Infestation—Methotrexate—colon cancer	0.000401	0.00109	CcSEcCtD
Hydromorphone—Depression—Methotrexate—colon cancer	0.0004	0.00109	CcSEcCtD
Hydromorphone—Vision blurred—Capecitabine—colon cancer	0.000396	0.00108	CcSEcCtD
Hydromorphone—Tremor—Capecitabine—colon cancer	0.000394	0.00108	CcSEcCtD
Hydromorphone—Stomatitis—Methotrexate—colon cancer	0.000391	0.00107	CcSEcCtD
Hydromorphone—Ill-defined disorder—Capecitabine—colon cancer	0.00039	0.00107	CcSEcCtD
Hydromorphone—Urticaria—Fluorouracil—colon cancer	0.00039	0.00107	CcSEcCtD
Hydromorphone—Body temperature increased—Fluorouracil—colon cancer	0.000388	0.00106	CcSEcCtD
Hydromorphone—Hypersensitivity—Vincristine—colon cancer	0.000388	0.00106	CcSEcCtD
Hydromorphone—Sweating—Methotrexate—colon cancer	0.000384	0.00105	CcSEcCtD
Hydromorphone—Malaise—Capecitabine—colon cancer	0.000379	0.00104	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Methotrexate—colon cancer	0.000379	0.00104	CcSEcCtD
Hydromorphone—Vertigo—Capecitabine—colon cancer	0.000378	0.00103	CcSEcCtD
Hydromorphone—Hypersensitivity—Irinotecan—colon cancer	0.000378	0.00103	CcSEcCtD
Hydromorphone—Asthenia—Vincristine—colon cancer	0.000378	0.00103	CcSEcCtD
Hydromorphone—Syncope—Capecitabine—colon cancer	0.000377	0.00103	CcSEcCtD
Hydromorphone—Leukopenia—Capecitabine—colon cancer	0.000377	0.00103	CcSEcCtD
Hydromorphone—Palpitations—Capecitabine—colon cancer	0.000372	0.00102	CcSEcCtD
Hydromorphone—Loss of consciousness—Capecitabine—colon cancer	0.00037	0.00101	CcSEcCtD
Hydromorphone—Asthenia—Irinotecan—colon cancer	0.000368	0.00101	CcSEcCtD
Hydromorphone—Cough—Capecitabine—colon cancer	0.000367	0.001	CcSEcCtD
Hydromorphone—Hypertension—Capecitabine—colon cancer	0.000363	0.000992	CcSEcCtD
Hydromorphone—Hypersensitivity—Fluorouracil—colon cancer	0.000362	0.000989	CcSEcCtD
Hydromorphone—Diarrhoea—Vincristine—colon cancer	0.00036	0.000985	CcSEcCtD
Hydromorphone—Chest pain—Capecitabine—colon cancer	0.000358	0.000978	CcSEcCtD
Hydromorphone—Myalgia—Capecitabine—colon cancer	0.000358	0.000978	CcSEcCtD
Hydromorphone—Arthralgia—Capecitabine—colon cancer	0.000358	0.000978	CcSEcCtD
Hydromorphone—Anxiety—Capecitabine—colon cancer	0.000357	0.000975	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000356	0.000972	CcSEcCtD
Hydromorphone—Urinary tract disorder—Methotrexate—colon cancer	0.000355	0.000971	CcSEcCtD
Hydromorphone—Discomfort—Capecitabine—colon cancer	0.000354	0.000967	CcSEcCtD
Hydromorphone—Urethral disorder—Methotrexate—colon cancer	0.000353	0.000963	CcSEcCtD
Hydromorphone—Diarrhoea—Irinotecan—colon cancer	0.000351	0.000959	CcSEcCtD
Hydromorphone—Dry mouth—Capecitabine—colon cancer	0.00035	0.000957	CcSEcCtD
Hydromorphone—Dizziness—Vincristine—colon cancer	0.000348	0.000952	CcSEcCtD
Hydromorphone—Pruritus—Fluorouracil—colon cancer	0.000348	0.00095	CcSEcCtD
Hydromorphone—Visual impairment—Methotrexate—colon cancer	0.000347	0.000947	CcSEcCtD
Hydromorphone—Confusional state—Capecitabine—colon cancer	0.000346	0.000946	CcSEcCtD
Hydromorphone—Infection—Capecitabine—colon cancer	0.000341	0.000932	CcSEcCtD
Hydromorphone—Dizziness—Irinotecan—colon cancer	0.000339	0.000927	CcSEcCtD
Hydromorphone—Shock—Capecitabine—colon cancer	0.000338	0.000923	CcSEcCtD
Hydromorphone—Nervous system disorder—Capecitabine—colon cancer	0.000337	0.00092	CcSEcCtD
Hydromorphone—Eye disorder—Methotrexate—colon cancer	0.000336	0.000918	CcSEcCtD
Hydromorphone—Diarrhoea—Fluorouracil—colon cancer	0.000336	0.000918	CcSEcCtD
Hydromorphone—Tinnitus—Methotrexate—colon cancer	0.000335	0.000916	CcSEcCtD
Hydromorphone—Tachycardia—Capecitabine—colon cancer	0.000335	0.000915	CcSEcCtD
Hydromorphone—Vomiting—Vincristine—colon cancer	0.000335	0.000915	CcSEcCtD
Hydromorphone—Cardiac disorder—Methotrexate—colon cancer	0.000334	0.000912	CcSEcCtD
Hydromorphone—Skin disorder—Capecitabine—colon cancer	0.000333	0.000911	CcSEcCtD
Hydromorphone—Rash—Vincristine—colon cancer	0.000332	0.000907	CcSEcCtD
Hydromorphone—Hyperhidrosis—Capecitabine—colon cancer	0.000332	0.000907	CcSEcCtD
Hydromorphone—Dermatitis—Vincristine—colon cancer	0.000332	0.000907	CcSEcCtD
Hydromorphone—Headache—Vincristine—colon cancer	0.00033	0.000902	CcSEcCtD
Hydromorphone—Anorexia—Capecitabine—colon cancer	0.000327	0.000894	CcSEcCtD
Hydromorphone—Angiopathy—Methotrexate—colon cancer	0.000326	0.000892	CcSEcCtD
Hydromorphone—Vomiting—Irinotecan—colon cancer	0.000326	0.000891	CcSEcCtD
Hydromorphone—Immune system disorder—Methotrexate—colon cancer	0.000325	0.000888	CcSEcCtD
Hydromorphone—Dizziness—Fluorouracil—colon cancer	0.000325	0.000888	CcSEcCtD
Hydromorphone—Mediastinal disorder—Methotrexate—colon cancer	0.000324	0.000886	CcSEcCtD
Hydromorphone—Rash—Irinotecan—colon cancer	0.000323	0.000884	CcSEcCtD
Hydromorphone—Dermatitis—Irinotecan—colon cancer	0.000323	0.000883	CcSEcCtD
Hydromorphone—Chills—Methotrexate—colon cancer	0.000323	0.000882	CcSEcCtD
Hydromorphone—Headache—Irinotecan—colon cancer	0.000321	0.000878	CcSEcCtD
Hydromorphone—Hypotension—Capecitabine—colon cancer	0.000321	0.000876	CcSEcCtD
Hydromorphone—Mental disorder—Methotrexate—colon cancer	0.000315	0.000861	CcSEcCtD
Hydromorphone—Malnutrition—Methotrexate—colon cancer	0.000313	0.000856	CcSEcCtD
Hydromorphone—Erythema—Methotrexate—colon cancer	0.000313	0.000856	CcSEcCtD
Hydromorphone—Nausea—Vincristine—colon cancer	0.000313	0.000855	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000313	0.000855	CcSEcCtD
Hydromorphone—Vomiting—Fluorouracil—colon cancer	0.000312	0.000853	CcSEcCtD
Hydromorphone—Insomnia—Capecitabine—colon cancer	0.000311	0.000848	CcSEcCtD
Hydromorphone—Rash—Fluorouracil—colon cancer	0.00031	0.000846	CcSEcCtD
Hydromorphone—Dermatitis—Fluorouracil—colon cancer	0.000309	0.000846	CcSEcCtD
Hydromorphone—Paraesthesia—Capecitabine—colon cancer	0.000308	0.000842	CcSEcCtD
Hydromorphone—Headache—Fluorouracil—colon cancer	0.000308	0.000841	CcSEcCtD
Hydromorphone—Dysgeusia—Methotrexate—colon cancer	0.000307	0.000838	CcSEcCtD
Hydromorphone—Dyspnoea—Capecitabine—colon cancer	0.000306	0.000836	CcSEcCtD
Hydromorphone—Nausea—Irinotecan—colon cancer	0.000305	0.000832	CcSEcCtD
Hydromorphone—Back pain—Methotrexate—colon cancer	0.000303	0.000828	CcSEcCtD
Hydromorphone—Dyspepsia—Capecitabine—colon cancer	0.000302	0.000826	CcSEcCtD
Hydromorphone—Decreased appetite—Capecitabine—colon cancer	0.000298	0.000815	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Capecitabine—colon cancer	0.000296	0.00081	CcSEcCtD
Hydromorphone—Fatigue—Capecitabine—colon cancer	0.000296	0.000809	CcSEcCtD
Hydromorphone—Vision blurred—Methotrexate—colon cancer	0.000295	0.000806	CcSEcCtD
Hydromorphone—Pain—Capecitabine—colon cancer	0.000294	0.000802	CcSEcCtD
Hydromorphone—Constipation—Capecitabine—colon cancer	0.000294	0.000802	CcSEcCtD
Hydromorphone—Nausea—Fluorouracil—colon cancer	0.000292	0.000797	CcSEcCtD
Hydromorphone—Ill-defined disorder—Methotrexate—colon cancer	0.000291	0.000794	CcSEcCtD
Hydromorphone—Feeling abnormal—Capecitabine—colon cancer	0.000283	0.000773	CcSEcCtD
Hydromorphone—Malaise—Methotrexate—colon cancer	0.000282	0.000772	CcSEcCtD
Hydromorphone—Vertigo—Methotrexate—colon cancer	0.000281	0.000769	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Capecitabine—colon cancer	0.000281	0.000767	CcSEcCtD
Hydromorphone—Leukopenia—Methotrexate—colon cancer	0.00028	0.000766	CcSEcCtD
Hydromorphone—Cough—Methotrexate—colon cancer	0.000273	0.000747	CcSEcCtD
Hydromorphone—Urticaria—Capecitabine—colon cancer	0.000273	0.000745	CcSEcCtD
Hydromorphone—Body temperature increased—Capecitabine—colon cancer	0.000271	0.000742	CcSEcCtD
Hydromorphone—Abdominal pain—Capecitabine—colon cancer	0.000271	0.000742	CcSEcCtD
Hydromorphone—Convulsion—Methotrexate—colon cancer	0.000271	0.000741	CcSEcCtD
Hydromorphone—Myalgia—Methotrexate—colon cancer	0.000267	0.000728	CcSEcCtD
Hydromorphone—Arthralgia—Methotrexate—colon cancer	0.000267	0.000728	CcSEcCtD
Hydromorphone—Chest pain—Methotrexate—colon cancer	0.000267	0.000728	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000265	0.000723	CcSEcCtD
Hydromorphone—Discomfort—Methotrexate—colon cancer	0.000263	0.00072	CcSEcCtD
Hydromorphone—Confusional state—Methotrexate—colon cancer	0.000258	0.000704	CcSEcCtD
Hydromorphone—Anaphylactic shock—Methotrexate—colon cancer	0.000256	0.000698	CcSEcCtD
Hydromorphone—Infection—Methotrexate—colon cancer	0.000254	0.000694	CcSEcCtD
Hydromorphone—Hypersensitivity—Capecitabine—colon cancer	0.000253	0.000691	CcSEcCtD
Hydromorphone—Nervous system disorder—Methotrexate—colon cancer	0.000251	0.000685	CcSEcCtD
Hydromorphone—Skin disorder—Methotrexate—colon cancer	0.000248	0.000678	CcSEcCtD
Hydromorphone—Hyperhidrosis—Methotrexate—colon cancer	0.000247	0.000675	CcSEcCtD
Hydromorphone—Asthenia—Capecitabine—colon cancer	0.000246	0.000673	CcSEcCtD
Hydromorphone—Anorexia—Methotrexate—colon cancer	0.000244	0.000666	CcSEcCtD
Hydromorphone—Pruritus—Capecitabine—colon cancer	0.000243	0.000664	CcSEcCtD
Hydromorphone—Hypotension—Methotrexate—colon cancer	0.000239	0.000652	CcSEcCtD
Hydromorphone—Diarrhoea—Capecitabine—colon cancer	0.000235	0.000642	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000233	0.000636	CcSEcCtD
Hydromorphone—Insomnia—Methotrexate—colon cancer	0.000231	0.000632	CcSEcCtD
Hydromorphone—Paraesthesia—Methotrexate—colon cancer	0.000229	0.000627	CcSEcCtD
Hydromorphone—Dyspnoea—Methotrexate—colon cancer	0.000228	0.000623	CcSEcCtD
Hydromorphone—Somnolence—Methotrexate—colon cancer	0.000227	0.000621	CcSEcCtD
Hydromorphone—Dizziness—Capecitabine—colon cancer	0.000227	0.00062	CcSEcCtD
Hydromorphone—Dyspepsia—Methotrexate—colon cancer	0.000225	0.000615	CcSEcCtD
Hydromorphone—Decreased appetite—Methotrexate—colon cancer	0.000222	0.000607	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Methotrexate—colon cancer	0.000221	0.000603	CcSEcCtD
Hydromorphone—Fatigue—Methotrexate—colon cancer	0.00022	0.000602	CcSEcCtD
Hydromorphone—Pain—Methotrexate—colon cancer	0.000219	0.000597	CcSEcCtD
Hydromorphone—Vomiting—Capecitabine—colon cancer	0.000218	0.000596	CcSEcCtD
Hydromorphone—Rash—Capecitabine—colon cancer	0.000216	0.000591	CcSEcCtD
Hydromorphone—Dermatitis—Capecitabine—colon cancer	0.000216	0.000591	CcSEcCtD
Hydromorphone—Headache—Capecitabine—colon cancer	0.000215	0.000588	CcSEcCtD
Hydromorphone—Feeling abnormal—Methotrexate—colon cancer	0.000211	0.000575	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Methotrexate—colon cancer	0.000209	0.000571	CcSEcCtD
Hydromorphone—Nausea—Capecitabine—colon cancer	0.000204	0.000557	CcSEcCtD
Hydromorphone—Urticaria—Methotrexate—colon cancer	0.000203	0.000555	CcSEcCtD
Hydromorphone—Abdominal pain—Methotrexate—colon cancer	0.000202	0.000552	CcSEcCtD
Hydromorphone—Body temperature increased—Methotrexate—colon cancer	0.000202	0.000552	CcSEcCtD
Hydromorphone—Hypersensitivity—Methotrexate—colon cancer	0.000188	0.000514	CcSEcCtD
Hydromorphone—Asthenia—Methotrexate—colon cancer	0.000183	0.000501	CcSEcCtD
Hydromorphone—Pruritus—Methotrexate—colon cancer	0.000181	0.000494	CcSEcCtD
Hydromorphone—Diarrhoea—Methotrexate—colon cancer	0.000175	0.000478	CcSEcCtD
Hydromorphone—Dizziness—Methotrexate—colon cancer	0.000169	0.000462	CcSEcCtD
Hydromorphone—Vomiting—Methotrexate—colon cancer	0.000162	0.000444	CcSEcCtD
Hydromorphone—Rash—Methotrexate—colon cancer	0.000161	0.00044	CcSEcCtD
Hydromorphone—Dermatitis—Methotrexate—colon cancer	0.000161	0.00044	CcSEcCtD
Hydromorphone—Headache—Methotrexate—colon cancer	0.00016	0.000437	CcSEcCtD
Hydromorphone—Nausea—Methotrexate—colon cancer	0.000152	0.000415	CcSEcCtD
